MDK and glioblastoma: Clonogenic growth of GBM cells was also significantly inhibited by combination treatment with Chk inhibitors and an MDK-antagonizing antibody compared to treatment with the anti-MDK antibody alone (Fig. 5e, Supplementary Fig. 14b, Supplementary Table 8).